Mixed phenotype is frequently identified in AML-MR. Future studies are needed to clarify how cases with MR gene mutations and TP53 mutations should be best classified. Additionally, MPAL, T/myeloid, and ETP-ALL and some genetically defined MPAL, B/myeloid, and B-ALL show phenotypic/genetic overlap and are challenging to diagnose. A genomic classification framework is proposed to separate AML-MR and precursor lymphoid neoplasms from MPAL.
Building similarity graph...
Analyzing shared references across papers
Loading...
Leonie Saft
Alexandar Tzankov
Alexandra Traverse-Glehen
American Journal of Clinical Pathology
The University of Texas Southwestern Medical Center
University Medical Center Utrecht
Karolinska University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Saft et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d8962d6c1944d70ce077d2 — DOI: https://doi.org/10.1093/ajcp/aqag019